In October 2022, DCC Healthcare made its largest acquisition to date by purchasing Medi-Globe, a prominent global manufacturer of minimally invasive medical products based in Germany. As a division of DCC Vital within the DCC Healthcare Division, Medi-Globe will enhance the distribution of medical products throughout the UK and Ireland.
This acquisition creates substantial growth opportunities through product innovation and additional acquisitions, drawing on DCC plc’s proven expertise in expansion through strategic acquisitions.
Founded in 1990, Medi-Globe specialises in developing, manufacturing, and distributing single-use devices for endoscopic procedures in gastroenterology, urology, and pulmonology.
The company operates with a state-of-the-art production facility in Europe and has expanded its market reach to over 120 countries, employing more than 580 people and generating sales of around 120 million Euros.
Medi-Globe’s portfolio includes notable brands like Medi-Globe, Urotech. The company also maintains a direct sales presence in Germany, France, Brazil, the Czech Republic, the Netherlands, and recently opened an office in China.
This acquisition not only strengthens DCC Healthcare’s footprint in the medical device industry but also positions Medi-Globe for continued success and innovation in the global marketplace.
Urology
Explore our range of urology products designed for kidney stone management, featuring access sheaths, catheters, guide wires, stone baskets, and solutions for urinary drainage and incontinence.
Gastroenterology
Explore our extensive range of endoscopic devices and instruments, perfectly suited for minimally invasive gastroenterological procedures like gastroscopy, colonoscopy, and ERCP.
Pulmonology
Explore our advanced minimally invasive pulmonology solutions with cutting-edge endobronchial ultrasound technology, offering superior rotatability, ergonomic handling, and enhanced safety.
